Vikki L. Conway - 25 Sep 2023 Form 3 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Exhibit 24 - Power of Attorney. Acting Head of Global Human Resources.
Signature
/s/ Dov Bergwerk, as attorney-in-fact for Vikki L. Conway
Issuer symbol
TEVA
Transactions as of
25 Sep 2023
Net transactions value
$0
Form type
3
Filing time
05 Oct 2023, 07:20:25 UTC
Next filing
16 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 2,268 $48.76 Direct F1, F2
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 3,504 $60.21 Direct F2, F3
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 8,003 $53.50 Direct F2, F4
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 15,003 $34.70 Direct F2, F5
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 4,571 $16.99 Direct F2, F6
holding TEVA Stock Options (right to buy) 25 Sep 2023 Ordinary Shares 25,003 $19.16 Direct F2, F7
holding TEVA Restricted Share Units 25 Sep 2023 Ordinary Shares 4,294 Direct F2, F8, F9
holding TEVA Restricted Share Units 25 Sep 2023 Ordinary Shares 9,911 Direct F2, F9, F10
holding TEVA Restricted Share Units 25 Sep 2023 Ordinary Shares 21,354 Direct F2, F9, F11
holding TEVA Restricted Share Units 25 Sep 2023 Ordinary Shares 20,717 Direct F2, F9, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options were granted on March 12, 2014, with 1,134 having vested on each of March 12, 2016 and March 12, 2017.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 Stock options were granted on March 12, 2015, with 876 having vested on each of March 12, 2016, March 12, 2017, March 12, 2018, and March 12, 2019.
F4 Stock options were granted on March 17, 2016, with 2,000 having vested on each of March 17, 2017, March 17, 2018 and March 12, 2019, and 2,003 having vested on March 17, 2020.
F5 Stock options were granted on March 3, 2017, with 3,750 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 3,753 having vested on March 3, 2021.
F6 Stock options were granted on September 18, 2017, with 4,571 having vested on September 18, 2019.
F7 Stock options were granted on March 2, 2018, with 6,250 having vested on each of March 2, 2019, March 2, 2020 and March 2, 2021, and 6,253 having vested on March 2, 2022.
F8 Restricted share units were granted on February 28, 2020, with 4,294 vesting on February 28, 2024.
F9 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F10 Restricted share units were granted on March 5, 2021, with 4,954 vesting on March 5, 2024, and 4,957 vesting on March 5, 2025.
F11 Restricted share units were granted on March 4, 2022, with 7,117 vesting on each of March 4, 2024 and March 4, 2025, and 7,120 vesting on March 4, 2026.
F12 Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027.

Remarks:

Exhibit 24 - Power of Attorney. Acting Head of Global Human Resources.